MedTrace Logo

Electrode Positions in Cardioverting Atrial Fibrillation

NCT03817372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 468

Last updated 2020-10-08

No results posted yet for this study

Summary

Atrial fibrillation is the most common heart rhythm disorder, and the incidence is rapidly increasing. Cardioversion using an electrical shock (DC-cardioversion) is an important treatment to reduce symptoms and improve patient's quality-of-life. The treatment is performed by applying gel electrodes to the chest. Cardioversion is not always successful, and it is unknown which electrode-position provides the optimal efficacy.

This study aims to compare two electrode positions, which are in clinical use: Anterior-posterior (left front and left back) versus anterior-lateral (right front and left side of the chest).

Conditions

Interventions

DEVICE

Anterior-posterior electrode position

Escalating energy shocks (100 J, 150 J, 200 J, 360 J) using anterior-posterior electrode position

DEVICE

Anterior-lateral electrode position

Escalating energy shocks (100 J, 150 J, 200 J, 360 J) using anterior-lateral electrode position

Sponsors & Collaborators

  • Regionshospitalet Viborg, Skive

    collaborator OTHER

  • Randers Regional Hospital

    collaborator OTHER

  • Regionshospitalet Horsens

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Anders S Schmidt, MD · Randers Regional Hospital

  • Consultant cardiologist Andi E Albertsen, MD, PhD · Viborg Regional Hospital

  • Professor Bo Løfgren, MD, PhD, FESC, FAHA · University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-19
Primary Completion
2020-10-02
Completion
2020-10-02

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817372 on ClinicalTrials.gov